tradingkey.logo
tradingkey.logo
Pesquisar

Bio-Techne Corp

TECH
Adicionar à lista de desejos
71.000USD
0.0000.00%
Fechamento 06/26, 16:00ETCotações atrasadas em 15 min
11.07BValor de mercado
100.60P/L TTM

Mais detalhes de Bio-Techne Corp Empresa

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.

Informações de Bio-Techne Corp

Código da empresaTECH
Nome da EmpresaBio-Techne Corp
Data de listagemFeb 09, 1989
CEOKelderman (Kim)
Número de funcionários3100
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 09
Endereço614 Mckinley Pl N E
CidadeMINNEAPOLIS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55413
Telefone16123798854
Sitehttps://www.bio-techne.com/
Código da empresaTECH
Data de listagemFeb 09, 1989
CEOKelderman (Kim)

Executivos da empresa Bio-Techne Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+2.45%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
65.80K
+4.17%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+3.53%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+10.64%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+14.93%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+18.69%
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
7.25K
+18.55%
Dr. Judith V. Klimovsky, M.D.
Dr. Judith V. Klimovsky, M.D.
Independent Director
Independent Director
3.78K
+43.36%
Mr. James T. (Jim) Hippel
Mr. James T. (Jim) Hippel
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
Mr. David Clair
Mr. David Clair
Investor Relations
Investor Relations
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+2.45%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
65.80K
+4.17%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+3.53%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+10.64%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+14.93%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+18.69%

Perguntas frequentes

Quem são os cinco principais acionistas de Bio-Techne Corp?

Os cinco principais acionistas de Bio-Techne Corp são: Mr. John L. Higgins

Quantas instituições possuem ações da Bio-Techne Corp (TECH)?

Em 2026Q1, 1247 instituições possuíam ações da Bio-Techne Corp, com valor de mercado aproximado de 178.19M, representando 113.81% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 1433.00.

Qual é a maior fonte de receita da Bio-Techne Corp?

Em 2026Q1, o segmento de negócios Consumables gerou a maior receita para Bio-Techne Corp, totalizando 235.44M e representando 79.57% da receita total.
KeyAI